Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ATOSSA THERAPEUTICS, INC. (ATOS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ATOSSA THERAPEUTICS, INC. (ATOS), most recent 12 months reported: net loss $37.71M, free cash flow -$35.78M. Latest balance sheet on file: liquid cash $26.09M. From SEC filings. Others in Pharmaceutical Preparations: Aprea Therapeutics, Inc. · APIMEDS PHARMACEUTICALS US, INC. · Aptevo Therapeutics Inc. · ARTELO BIOSCIENCES, INC. · ARRIVENT BIOPHARMA, INC. · Atea Pharmaceuticals, Inc. · Azitra, Inc. · BridgeBio Oncology Therapeutics, Inc.

Stock screener

Watchlist